-
Mashup Score: 39Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment - 12 hour(s) ago
Acquisition advances Johnson & Johnson’s leading Dermatology portfolio with opportunity to address significant unmet need in atopic dermatitis (AD) Includes bispecific antibodies targeting proven disease pathways and offers the potential to provide best-in-disease therapeutics for people with moderate to severe AD and asthma These pipeline additions demonstrate the Company’s strategic approach to build a portfolio of differentiated and complementary bispecifics to address multiple disease-driving pathways
Source: www.jnj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 26Reconnecting the meaning of these two simple words: Health&Care - 22 day(s) ago
Johnson & Johnson is restoring the true meaning of healthcare by developing advanced treatments and smarter and less invasive solutions for today’s most complex diseases.
Source: www.jnj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 7
Here’s an infographic breakdown of the company’s first-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.
Source: www.jnj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 12
Complete this form to enter the webcast. (* indicates required
Source: event.webcasts.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 12
Complete this form to enter the webcast. (* indicates required
Source: event.webcasts.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 27Global Health Equity - 1 month(s) ago
We are closing the gap between communities and care by enabling access to our medicines and technologies, championing nurses and health workers and working together with community-based organizations. Johnson & Johnson supports more than 100 community-led organizations in marginalized communities to provide resources and tools to advance accessible, quality health care in the U.S. There is no single solution to addressing global health inequities. To improve health outcomes worldwide, we take on these
Source: www.jnj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 88Johnson & Johnson to Acquire Shockwave Medical - 1 month(s) ago
Enhances Johnson & Johnson’s Ability to Transform the Treatment Landscape for Cardiovascular Disease and Continue to Improve Patient Outcomes Extends Johnson & Johnson MedTech’s Position in Highest-Growth, Innovation-Oriented Segments of Cardiovascular Intervention Accelerates Sales Growth and Accretive to Operating Margin for Both Johnson & Johnson and Johnson & Johnson MedTech Conference Call at 8:30 a.m. ET To Discuss Details of the Transaction
Source: www.jnj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 25Global Health Equity - 1 month(s) ago
We are closing the gap between communities and care by enabling access to our medicines and technologies, championing nurses and health workers and working together with community-based organizations. Johnson & Johnson supports more than 100 community-led organizations in marginalized communities to provide resources and tools to advance accessible, quality health care in the U.S. There is no single solution to addressing global health inequities. To improve health outcomes worldwide, we take on these
Source: www.jnj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 24
The company’s drive to develop novel solutions for the world’s toughest healthcare challenges has earned it a spot on Fortune’s second annual list.
Source: www.jnj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 12
For Arthritis Awareness Month, learn how Johnson & Johnson MedTech is innovating to help improve outcomes with this complex procedure.
Source: www.jnj.comCategories: General Medicine News, PayerTweet
Johnson & Johnson has entered into a definitive agreement to acquire Proteologix, Inc., a biotechnology company focused on bispecific antibodies for immune-mediated diseases. Click here for more information: https://t.co/9N8FsGwydj #JNJImmunology #Innovation https://t.co/Z4RI9V6klv